0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gabapentin Drug Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-7M7176
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gabapentin Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Gabapentin Drug Market Research Report 2025

Code: QYRE-Auto-7M7176
Report
August 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gabapentin Drug Market Size

The global market for Gabapentin Drug was valued at US$ 1658 million in the year 2024 and is projected to reach a revised size of US$ 2116 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Gabapentin Drug Market

Gabapentin Drug Market

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gabapentin Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gabapentin Drug.
The Gabapentin Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gabapentin Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gabapentin Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gabapentin Drug Market Report

Report Metric Details
Report Name Gabapentin Drug Market
Accounted market size in year US$ 1658 million
Forecasted market size in 2031 US$ 2116 million
CAGR 3.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Capsule
  • Tablet
  • Oral Solution
Segment by Application
  • Postherpetic Neuralgia in Adults
  • Partial Onset Seizures
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Depomed, Apotex, Teva, Acella Pharmaceuticals, Taro, Sun Pharmaceutical, Glenmark, Amneal Pharmaceuticals, Aurobindo Pharma, Zydus Pharmaceuticals, Hi-Tech Pharmaceuticals, Marksans Pharma, Mylan, InvaGen Pharmaceuticals, Alkem Laboratories, Tris Pharma, ACI HealthCare Limited, Jiangsu Hengrui Medicine, CSPC Ouyi Pharmaceutical, Sciegen Pharmaceuticals, Epic Pharma, Lupin Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gabapentin Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gabapentin Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Gabapentin Drug Market growing?

Ans: The Gabapentin Drug Market witnessing a CAGR of 3.6% during the forecast period 2025-2031.

What is the Gabapentin Drug Market size in 2031?

Ans: The Gabapentin Drug Market size in 2031 will be US$ 2116 million.

Who are the main players in the Gabapentin Drug Market report?

Ans: The main players in the Gabapentin Drug Market are Pfizer, Depomed, Apotex, Teva, Acella Pharmaceuticals, Taro, Sun Pharmaceutical, Glenmark, Amneal Pharmaceuticals, Aurobindo Pharma, Zydus Pharmaceuticals, Hi-Tech Pharmaceuticals, Marksans Pharma, Mylan, InvaGen Pharmaceuticals, Alkem Laboratories, Tris Pharma, ACI HealthCare Limited, Jiangsu Hengrui Medicine, CSPC Ouyi Pharmaceutical, Sciegen Pharmaceuticals, Epic Pharma, Lupin Limited

What are the Application segmentation covered in the Gabapentin Drug Market report?

Ans: The Applications covered in the Gabapentin Drug Market report are Postherpetic Neuralgia in Adults, Partial Onset Seizures, Others

What are the Type segmentation covered in the Gabapentin Drug Market report?

Ans: The Types covered in the Gabapentin Drug Market report are Capsule, Tablet, Oral Solution

Recommended Reports

Neuropathic Pain Drugs

Epilepsy and CNS

Bladder and Gynecology

1 Gabapentin Drug Market Overview
1.1 Product Definition
1.2 Gabapentin Drug by Type
1.2.1 Global Gabapentin Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Oral Solution
1.3 Gabapentin Drug by Application
1.3.1 Global Gabapentin Drug Market Value by Application (2024 VS 2031)
1.3.2 Postherpetic Neuralgia in Adults
1.3.3 Partial Onset Seizures
1.3.4 Others
1.4 Global Gabapentin Drug Market Size Estimates and Forecasts
1.4.1 Global Gabapentin Drug Revenue 2020-2031
1.4.2 Global Gabapentin Drug Sales 2020-2031
1.4.3 Global Gabapentin Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gabapentin Drug Market Competition by Manufacturers
2.1 Global Gabapentin Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gabapentin Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gabapentin Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gabapentin Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gabapentin Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gabapentin Drug, Product Type & Application
2.7 Global Key Manufacturers of Gabapentin Drug, Date of Enter into This Industry
2.8 Global Gabapentin Drug Market Competitive Situation and Trends
2.8.1 Global Gabapentin Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gabapentin Drug Players Market Share by Revenue
2.8.3 Global Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gabapentin Drug Market Scenario by Region
3.1 Global Gabapentin Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gabapentin Drug Sales by Region: 2020-2031
3.2.1 Global Gabapentin Drug Sales by Region: 2020-2025
3.2.2 Global Gabapentin Drug Sales by Region: 2026-2031
3.3 Global Gabapentin Drug Revenue by Region: 2020-2031
3.3.1 Global Gabapentin Drug Revenue by Region: 2020-2025
3.3.2 Global Gabapentin Drug Revenue by Region: 2026-2031
3.4 North America Gabapentin Drug Market Facts & Figures by Country
3.4.1 North America Gabapentin Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gabapentin Drug Sales by Country (2020-2031)
3.4.3 North America Gabapentin Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gabapentin Drug Market Facts & Figures by Country
3.5.1 Europe Gabapentin Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gabapentin Drug Sales by Country (2020-2031)
3.5.3 Europe Gabapentin Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gabapentin Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Gabapentin Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gabapentin Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Gabapentin Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Gabapentin Drug Market Facts & Figures by Country
3.7.1 Latin America Gabapentin Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gabapentin Drug Sales by Country (2020-2031)
3.7.3 Latin America Gabapentin Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gabapentin Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Gabapentin Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gabapentin Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gabapentin Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gabapentin Drug Sales by Type (2020-2031)
4.1.1 Global Gabapentin Drug Sales by Type (2020-2025)
4.1.2 Global Gabapentin Drug Sales by Type (2026-2031)
4.1.3 Global Gabapentin Drug Sales Market Share by Type (2020-2031)
4.2 Global Gabapentin Drug Revenue by Type (2020-2031)
4.2.1 Global Gabapentin Drug Revenue by Type (2020-2025)
4.2.2 Global Gabapentin Drug Revenue by Type (2026-2031)
4.2.3 Global Gabapentin Drug Revenue Market Share by Type (2020-2031)
4.3 Global Gabapentin Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gabapentin Drug Sales by Application (2020-2031)
5.1.1 Global Gabapentin Drug Sales by Application (2020-2025)
5.1.2 Global Gabapentin Drug Sales by Application (2026-2031)
5.1.3 Global Gabapentin Drug Sales Market Share by Application (2020-2031)
5.2 Global Gabapentin Drug Revenue by Application (2020-2031)
5.2.1 Global Gabapentin Drug Revenue by Application (2020-2025)
5.2.2 Global Gabapentin Drug Revenue by Application (2026-2031)
5.2.3 Global Gabapentin Drug Revenue Market Share by Application (2020-2031)
5.3 Global Gabapentin Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Gabapentin Drug Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Depomed
6.2.1 Depomed Company Information
6.2.2 Depomed Description and Business Overview
6.2.3 Depomed Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Depomed Gabapentin Drug Product Portfolio
6.2.5 Depomed Recent Developments/Updates
6.3 Apotex
6.3.1 Apotex Company Information
6.3.2 Apotex Description and Business Overview
6.3.3 Apotex Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Apotex Gabapentin Drug Product Portfolio
6.3.5 Apotex Recent Developments/Updates
6.4 Teva
6.4.1 Teva Company Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Gabapentin Drug Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Acella Pharmaceuticals
6.5.1 Acella Pharmaceuticals Company Information
6.5.2 Acella Pharmaceuticals Description and Business Overview
6.5.3 Acella Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Acella Pharmaceuticals Gabapentin Drug Product Portfolio
6.5.5 Acella Pharmaceuticals Recent Developments/Updates
6.6 Taro
6.6.1 Taro Company Information
6.6.2 Taro Description and Business Overview
6.6.3 Taro Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Taro Gabapentin Drug Product Portfolio
6.6.5 Taro Recent Developments/Updates
6.7 Sun Pharmaceutical
6.7.1 Sun Pharmaceutical Company Information
6.7.2 Sun Pharmaceutical Description and Business Overview
6.7.3 Sun Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sun Pharmaceutical Gabapentin Drug Product Portfolio
6.7.5 Sun Pharmaceutical Recent Developments/Updates
6.8 Glenmark
6.8.1 Glenmark Company Information
6.8.2 Glenmark Description and Business Overview
6.8.3 Glenmark Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Glenmark Gabapentin Drug Product Portfolio
6.8.5 Glenmark Recent Developments/Updates
6.9 Amneal Pharmaceuticals
6.9.1 Amneal Pharmaceuticals Company Information
6.9.2 Amneal Pharmaceuticals Description and Business Overview
6.9.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Amneal Pharmaceuticals Gabapentin Drug Product Portfolio
6.9.5 Amneal Pharmaceuticals Recent Developments/Updates
6.10 Aurobindo Pharma
6.10.1 Aurobindo Pharma Company Information
6.10.2 Aurobindo Pharma Description and Business Overview
6.10.3 Aurobindo Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Aurobindo Pharma Gabapentin Drug Product Portfolio
6.10.5 Aurobindo Pharma Recent Developments/Updates
6.11 Zydus Pharmaceuticals
6.11.1 Zydus Pharmaceuticals Company Information
6.11.2 Zydus Pharmaceuticals Description and Business Overview
6.11.3 Zydus Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zydus Pharmaceuticals Gabapentin Drug Product Portfolio
6.11.5 Zydus Pharmaceuticals Recent Developments/Updates
6.12 Hi-Tech Pharmaceuticals
6.12.1 Hi-Tech Pharmaceuticals Company Information
6.12.2 Hi-Tech Pharmaceuticals Description and Business Overview
6.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolio
6.12.5 Hi-Tech Pharmaceuticals Recent Developments/Updates
6.13 Marksans Pharma
6.13.1 Marksans Pharma Company Information
6.13.2 Marksans Pharma Description and Business Overview
6.13.3 Marksans Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Marksans Pharma Gabapentin Drug Product Portfolio
6.13.5 Marksans Pharma Recent Developments/Updates
6.14 Mylan
6.14.1 Mylan Company Information
6.14.2 Mylan Description and Business Overview
6.14.3 Mylan Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Mylan Gabapentin Drug Product Portfolio
6.14.5 Mylan Recent Developments/Updates
6.15 InvaGen Pharmaceuticals
6.15.1 InvaGen Pharmaceuticals Company Information
6.15.2 InvaGen Pharmaceuticals Description and Business Overview
6.15.3 InvaGen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.15.4 InvaGen Pharmaceuticals Gabapentin Drug Product Portfolio
6.15.5 InvaGen Pharmaceuticals Recent Developments/Updates
6.16 Alkem Laboratories
6.16.1 Alkem Laboratories Company Information
6.16.2 Alkem Laboratories Description and Business Overview
6.16.3 Alkem Laboratories Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Alkem Laboratories Gabapentin Drug Product Portfolio
6.16.5 Alkem Laboratories Recent Developments/Updates
6.17 Tris Pharma
6.17.1 Tris Pharma Company Information
6.17.2 Tris Pharma Description and Business Overview
6.17.3 Tris Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Tris Pharma Gabapentin Drug Product Portfolio
6.17.5 Tris Pharma Recent Developments/Updates
6.18 ACI HealthCare Limited
6.18.1 ACI HealthCare Limited Company Information
6.18.2 ACI HealthCare Limited Description and Business Overview
6.18.3 ACI HealthCare Limited Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.18.4 ACI HealthCare Limited Gabapentin Drug Product Portfolio
6.18.5 ACI HealthCare Limited Recent Developments/Updates
6.19 Jiangsu Hengrui Medicine
6.19.1 Jiangsu Hengrui Medicine Company Information
6.19.2 Jiangsu Hengrui Medicine Description and Business Overview
6.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolio
6.19.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.20 CSPC Ouyi Pharmaceutical
6.20.1 CSPC Ouyi Pharmaceutical Company Information
6.20.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.20.4 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolio
6.20.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.21 Sciegen Pharmaceuticals
6.21.1 Sciegen Pharmaceuticals Company Information
6.21.2 Sciegen Pharmaceuticals Description and Business Overview
6.21.3 Sciegen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Sciegen Pharmaceuticals Gabapentin Drug Product Portfolio
6.21.5 Sciegen Pharmaceuticals Recent Developments/Updates
6.22 Epic Pharma
6.22.1 Epic Pharma Company Information
6.22.2 Epic Pharma Description and Business Overview
6.22.3 Epic Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Epic Pharma Gabapentin Drug Product Portfolio
6.22.5 Epic Pharma Recent Developments/Updates
6.23 Lupin Limited
6.23.1 Lupin Limited Company Information
6.23.2 Lupin Limited Description and Business Overview
6.23.3 Lupin Limited Gabapentin Drug Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Lupin Limited Gabapentin Drug Product Portfolio
6.23.5 Lupin Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gabapentin Drug Industry Chain Analysis
7.2 Gabapentin Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gabapentin Drug Production Mode & Process Analysis
7.4 Gabapentin Drug Sales and Marketing
7.4.1 Gabapentin Drug Sales Channels
7.4.2 Gabapentin Drug Distributors
7.5 Gabapentin Drug Customer Analysis
8 Gabapentin Drug Market Dynamics
8.1 Gabapentin Drug Industry Trends
8.2 Gabapentin Drug Market Drivers
8.3 Gabapentin Drug Market Challenges
8.4 Gabapentin Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Gabapentin Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gabapentin Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gabapentin Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gabapentin Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Gabapentin Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gabapentin Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gabapentin Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gabapentin Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gabapentin Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gabapentin Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gabapentin Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Gabapentin Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gabapentin Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gabapentin Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gabapentin Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Gabapentin Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Gabapentin Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Gabapentin Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Gabapentin Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gabapentin Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Gabapentin Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gabapentin Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Gabapentin Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gabapentin Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Gabapentin Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Gabapentin Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gabapentin Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gabapentin Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gabapentin Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Gabapentin Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Gabapentin Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gabapentin Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gabapentin Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gabapentin Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Gabapentin Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Gabapentin Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gabapentin Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gabapentin Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gabapentin Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Gabapentin Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Gabapentin Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gabapentin Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gabapentin Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gabapentin Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Gabapentin Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Gabapentin Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gabapentin Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gabapentin Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Gabapentin Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Gabapentin Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Gabapentin Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Gabapentin Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gabapentin Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gabapentin Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Gabapentin Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Gabapentin Drug Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Gabapentin Drug Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Gabapentin Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Gabapentin Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Gabapentin Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Gabapentin Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Gabapentin Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gabapentin Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gabapentin Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Gabapentin Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Gabapentin Drug Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Gabapentin Drug Price (USD/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Gabapentin Drug Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Depomed Company Information
 Table 76. Depomed Description and Business Overview
 Table 77. Depomed Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Depomed Gabapentin Drug Product
 Table 79. Depomed Recent Developments/Updates
 Table 80. Apotex Company Information
 Table 81. Apotex Description and Business Overview
 Table 82. Apotex Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Apotex Gabapentin Drug Product
 Table 84. Apotex Recent Developments/Updates
 Table 85. Teva Company Information
 Table 86. Teva Description and Business Overview
 Table 87. Teva Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Teva Gabapentin Drug Product
 Table 89. Teva Recent Developments/Updates
 Table 90. Acella Pharmaceuticals Company Information
 Table 91. Acella Pharmaceuticals Description and Business Overview
 Table 92. Acella Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Acella Pharmaceuticals Gabapentin Drug Product
 Table 94. Acella Pharmaceuticals Recent Developments/Updates
 Table 95. Taro Company Information
 Table 96. Taro Description and Business Overview
 Table 97. Taro Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Taro Gabapentin Drug Product
 Table 99. Taro Recent Developments/Updates
 Table 100. Sun Pharmaceutical Company Information
 Table 101. Sun Pharmaceutical Description and Business Overview
 Table 102. Sun Pharmaceutical Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Sun Pharmaceutical Gabapentin Drug Product
 Table 104. Sun Pharmaceutical Recent Developments/Updates
 Table 105. Glenmark Company Information
 Table 106. Glenmark Description and Business Overview
 Table 107. Glenmark Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Glenmark Gabapentin Drug Product
 Table 109. Glenmark Recent Developments/Updates
 Table 110. Amneal Pharmaceuticals Company Information
 Table 111. Amneal Pharmaceuticals Description and Business Overview
 Table 112. Amneal Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Amneal Pharmaceuticals Gabapentin Drug Product
 Table 114. Amneal Pharmaceuticals Recent Developments/Updates
 Table 115. Aurobindo Pharma Company Information
 Table 116. Aurobindo Pharma Description and Business Overview
 Table 117. Aurobindo Pharma Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Aurobindo Pharma Gabapentin Drug Product
 Table 119. Aurobindo Pharma Recent Developments/Updates
 Table 120. Zydus Pharmaceuticals Company Information
 Table 121. Zydus Pharmaceuticals Description and Business Overview
 Table 122. Zydus Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Zydus Pharmaceuticals Gabapentin Drug Product
 Table 124. Zydus Pharmaceuticals Recent Developments/Updates
 Table 125. Hi-Tech Pharmaceuticals Company Information
 Table 126. Hi-Tech Pharmaceuticals Description and Business Overview
 Table 127. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Hi-Tech Pharmaceuticals Gabapentin Drug Product
 Table 129. Hi-Tech Pharmaceuticals Recent Developments/Updates
 Table 130. Marksans Pharma Company Information
 Table 131. Marksans Pharma Description and Business Overview
 Table 132. Marksans Pharma Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Marksans Pharma Gabapentin Drug Product
 Table 134. Marksans Pharma Recent Developments/Updates
 Table 135. Mylan Company Information
 Table 136. Mylan Description and Business Overview
 Table 137. Mylan Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Mylan Gabapentin Drug Product
 Table 139. Mylan Recent Developments/Updates
 Table 140. InvaGen Pharmaceuticals Company Information
 Table 141. InvaGen Pharmaceuticals Description and Business Overview
 Table 142. InvaGen Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. InvaGen Pharmaceuticals Gabapentin Drug Product
 Table 144. InvaGen Pharmaceuticals Recent Developments/Updates
 Table 145. Alkem Laboratories Company Information
 Table 146. Alkem Laboratories Description and Business Overview
 Table 147. Alkem Laboratories Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Alkem Laboratories Gabapentin Drug Product
 Table 149. Alkem Laboratories Recent Developments/Updates
 Table 150. Tris Pharma Company Information
 Table 151. Tris Pharma Description and Business Overview
 Table 152. Tris Pharma Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. Tris Pharma Gabapentin Drug Product
 Table 154. Tris Pharma Recent Developments/Updates
 Table 155. ACI HealthCare Limited Company Information
 Table 156. ACI HealthCare Limited Description and Business Overview
 Table 157. ACI HealthCare Limited Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 158. ACI HealthCare Limited Gabapentin Drug Product
 Table 159. ACI HealthCare Limited Recent Developments/Updates
 Table 160. Jiangsu Hengrui Medicine Company Information
 Table 161. Jiangsu Hengrui Medicine Description and Business Overview
 Table 162. Jiangsu Hengrui Medicine Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 163. Jiangsu Hengrui Medicine Gabapentin Drug Product
 Table 164. Jiangsu Hengrui Medicine Recent Developments/Updates
 Table 165. CSPC Ouyi Pharmaceutical Company Information
 Table 166. CSPC Ouyi Pharmaceutical Description and Business Overview
 Table 167. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 168. CSPC Ouyi Pharmaceutical Gabapentin Drug Product
 Table 169. CSPC Ouyi Pharmaceutical Recent Developments/Updates
 Table 170. Sciegen Pharmaceuticals Company Information
 Table 171. Sciegen Pharmaceuticals Description and Business Overview
 Table 172. Sciegen Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 173. Sciegen Pharmaceuticals Gabapentin Drug Product
 Table 174. Sciegen Pharmaceuticals Recent Developments/Updates
 Table 175. Epic Pharma Company Information
 Table 176. Epic Pharma Description and Business Overview
 Table 177. Epic Pharma Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 178. Epic Pharma Gabapentin Drug Product
 Table 179. Epic Pharma Recent Developments/Updates
 Table 180. Lupin Limited Company Information
 Table 181. Lupin Limited Description and Business Overview
 Table 182. Lupin Limited Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 183. Lupin Limited Gabapentin Drug Product
 Table 184. Lupin Limited Recent Developments/Updates
 Table 185. Key Raw Materials Lists
 Table 186. Raw Materials Key Suppliers Lists
 Table 187. Gabapentin Drug Distributors List
 Table 188. Gabapentin Drug Customers List
 Table 189. Gabapentin Drug Market Trends
 Table 190. Gabapentin Drug Market Drivers
 Table 191. Gabapentin Drug Market Challenges
 Table 192. Gabapentin Drug Market Restraints
 Table 193. Research Programs/Design for This Report
 Table 194. Key Data Information from Secondary Sources
 Table 195. Key Data Information from Primary Sources
 Table 196. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gabapentin Drug
 Figure 2. Global Gabapentin Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gabapentin Drug Market Share by Type: 2024 & 2031
 Figure 4. Capsule Product Picture
 Figure 5. Tablet Product Picture
 Figure 6. Oral Solution Product Picture
 Figure 7. Global Gabapentin Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Gabapentin Drug Market Share by Application: 2024 & 2031
 Figure 9. Postherpetic Neuralgia in Adults
 Figure 10. Partial Onset Seizures
 Figure 11. Others
 Figure 12. Global Gabapentin Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Gabapentin Drug Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Gabapentin Drug Sales (2020-2031) & (K Units)
 Figure 15. Global Gabapentin Drug Average Price (USD/Unit) & (2020-2031)
 Figure 16. Gabapentin Drug Report Years Considered
 Figure 17. Gabapentin Drug Sales Share by Manufacturers in 2024
 Figure 18. Global Gabapentin Drug Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Gabapentin Drug Players: Market Share by Revenue in Gabapentin Drug in 2024
 Figure 20. Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Gabapentin Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Gabapentin Drug Sales Market Share by Country (2020-2031)
 Figure 23. North America Gabapentin Drug Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Gabapentin Drug Sales Market Share by Country (2020-2031)
 Figure 27. Europe Gabapentin Drug Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Gabapentin Drug Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Gabapentin Drug Revenue Market Share by Region (2020-2031)
 Figure 35. China Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Gabapentin Drug Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Gabapentin Drug Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Gabapentin Drug Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Gabapentin Drug Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Gabapentin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Gabapentin Drug by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Gabapentin Drug by Type (2020-2031)
 Figure 57. Global Gabapentin Drug Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Gabapentin Drug by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Gabapentin Drug by Application (2020-2031)
 Figure 60. Global Gabapentin Drug Price (USD/Unit) by Application (2020-2031)
 Figure 61. Gabapentin Drug Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools